GX-585

CAS No. 2098540-08-8

GX-585( —— )

Catalog No. M36315 CAS No. 2098540-08-8

GX-585 is a sulfonamide analog that is a Nav 1.7 channel inhibitor with analgesic activity for the study of neuropathic pain and inflammation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 683 In Stock
10MG 938 In Stock
25MG 1416 In Stock
50MG 1841 In Stock
100MG 2558 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GX-585
  • Note
    Research use only, not for human use.
  • Brief Description
    GX-585 is a sulfonamide analog that is a Nav 1.7 channel inhibitor with analgesic activity for the study of neuropathic pain and inflammation.
  • Description
    GX-585 is a sulfonamide analog that is a Nav 1.7 channel inhibitor with analgesic activity for the study of neuropathic pain and inflammation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2098540-08-8
  • Formula Weight
    539.45
  • Molecular Formula
    C24H25Cl2FN4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=2C(N(N1)[C@H]3CN([C@H](C)C4=CC(Cl)=CC(Cl)=C4)CC3)=CC(F)=C(C(NS(=O)(=O)C5CC5)=O)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Metaflumizone

    Metaflumizone is a sodium channel blocker insecticide.

  • Elpetrigine

    Elpetrigine (GW273293) is a potential sodium channel blocker with antiepileptic activity that can be used to study epilepsy.

  • Trapencaine

    Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.